Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

How to Lower Blood Cholesterol Levels: Natural and Pharmacologic Options

Medically reviewed by 
How to Lower Blood Cholesterol Levels: Natural and Pharmacologic Options

Managing blood cholesterol levels is crucial for keeping a person’s heart in top shape. Elevated or unbalanced cholesterol can lead to cardiovascular disease and stroke, making it important to take proactive steps. We can tackle this challenge using both natural and medical methods. 

Natural approaches to managing blood cholesterol levels include dietary and lifestyle modifications and also the use of supplements. A diet rich in fruits, vegetables, and whole grains, and low in unhealthy fats, forms the core of managing cholesterol naturally. 

On the medical side, there are pharmacologic interventions (medications) that are used to lower blood cholesterol levels. These medications offer different paths to lower cholesterol, especially when dietary and lifestyle changes alone are not enough. Balancing the natural and medical strategies is key for personalized and effective cholesterol management. Regular visits with healthcare professionals help to ensure the treatment plan is effective, that a person stays on the right track, and empowers them to take charge of their heart health.


Understanding Cholesterol and Its Impact on Health

Cholesterol, a fatty substance produced by the liver and found in certain foods, serves important roles in the body. It contributes to the building of cell membranes, forms hormones, aids digestion, and supports vitamin D production. However, an imbalance in cholesterol levels can pose serious health risks. When low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol is too high, it can lead to the buildup of plaque in arteries. This buildup of plaque narrows arteries, restricting blood flow and increasing the risk of cardiovascular disease. Additionally, this may increase the risk of developing blood clots that can cause strokes. High cholesterol often goes unnoticed as it often shows no apparent symptoms, emphasizing the importance of regular screenings. 

Unmanaged cholesterol levels elevate the risk of atherosclerosis. Atherosclerosis is where arteries narrow and harden, potentially leading to a heart attack. Achieving a balance in cholesterol levels is crucial for cardiovascular health, highlighting the need for awareness, lifestyle changes, and medical interventions to reduce the health risks of high cholesterol. Routine monitoring and proactive management play vital roles in sustaining a healthy balance and preventing potential heart-related complications.

Testing and Monitoring Cholesterol Levels

Regular monitoring of cholesterol using a blood test called a lipid panel is key for cardiovascular health. A lipid or cholesterol panel provides a comprehensive assessment of serum total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides. Total cholesterol reflects the overall cholesterol level, while LDL cholesterol is often referred to as "bad" cholesterol, and HDL as "good" cholesterol. Triglycerides are another type of fat (or lipid) in the blood. High levels of triglycerides can increase a person’s risk for heart disease and stroke. Other tests that may be used to assess cardiovascular risk include biomarkers such as apolipoprotein A (ApoE), inflammatory markers such as C-reactive protein (CRP), and an amino acid called homocysteine. All of these tests are offered by Access Medical Labs. (4,35,16)

The frequency of cholesterol testing depends on factors such as a person’s age, health status, and risk factors for heart disease. As a general guideline, the American Heart Association recommends testing every four to six years for people 20 years of age or older, with more frequent testing for those with select risk factors such as smoking, history of high cholesterol, heart disease, diabetes, genetic risk factors, or other cardiovascular conditions. Healthcare providers may recommend more frequent testing based on a person’s risk factors for heart disease.

The results of these facilitate guiding the development of treatment plans for cholesterol management. For example, elevated LDL levels may prompt lifestyle modifications such as dietary changes and increased physical activity. In cases where lifestyle adjustments are insufficient, medications like statins or other cholesterol-lowering drugs may be prescribed. Regular testing of cholesterol levels not only allows for early detection of potential issues but also enables healthcare providers to tailor interventions based on individual needs, promoting proactive management of cholesterol levels and reducing the risk of cardiovascular complications.


Pharmacologic Options for Cholesterol Management 

Common pharmacologic treatments for high cholesterol consist of medications designed to effectively lower lipid levels and mitigate cardiovascular risks. Statins are a class of drugs that are commonly prescribed to reduce the liver's cholesterol production and enhance the removal of LDL cholesterol from the blood. Another class of medications is non-statins. These include bile acid sequestrants (cholestyramine) that work by binding to bile acids, stimulating the liver to use more cholesterol to generate additional bile acids and ultimately lowering LDL cholesterol levels and cholesterol absorption inhibitors (ezetimibe) which impede cholesterol absorption in the gastrointestinal system and lead to a reduction in LDL cholesterol levels.

Despite their effectiveness, it is important to be aware of potential side effects associated with these medications. For example, in some people, statins may result in muscle aches, abnormalities in liver enzymes, or, rarely, cause more severe conditions such as rhabdomyolysis. Rhabdomyolysis is a medical condition that occurs when muscle tissue breaks down, releasing a protein called myoglobin into the bloodstream. When myoglobin is released into the bloodstream, it can cause kidney damage, as the kidneys may struggle to filter and eliminate this protein effectively. Non-statin medications may also have side effects. Bile acid sequestrants may induce gastrointestinal discomfort, while cholesterol absorption inhibitors might lead to diarrhea or abdominal pain. Responses to these medications vary by individual. Individuals need to consult with their healthcare provider to ensure the optimal balance between cholesterol control and overall well-being.

Natural Approaches to Lowering Cholesterol

Natural approaches to lowering cholesterol involve a combined approach, consisting of dietary strategies, physical activity, and weight management. Dietary strategies for cholesterol management consist of eating a heart-healthy diet. A heart-healthy diet consists of high-fiber foods like fruits, vegetables, and whole grains. These foods play a significant role in lowering levels of LDL cholesterol. Incorporating healthy fats from food sources like avocados, nuts, and olive oil further promotes a balanced serum lipid profile. 

In addition to these dietary components, cholesterol management can be achieved by using natural substances like red yeast rice and plant sterols.  

  • Red yeast rice contains monacolins, which reduce an enzyme (HMG-CoA) that plays a role in cholesterol production by the liver. By reducing this enzyme, red yeast rice has been found to lower cholesterol. 
  • Plant sterols (phytosterols) are naturally occurring compounds found in plants that have a structure similar to cholesterol. These plant sterols can help lower LDL cholesterol levels by competing with cholesterol absorption in the digestive system. Common examples of plant sterols and their sources include:
  • Beta-sitosterol: Found in plant-based oils, nuts, seeds, and legumes
  • Campesterol: Present in foods like vegetable oils, whole grains, nuts, and seeds
  • Sitostanol: Found in plant-based oils, nuts, seeds, and whole grains
  • Brassicasterol: Found in brassica vegetables such as broccoli, brussels sprouts, and cabbage, and some nuts and seeds
  • Avocado Sterols: Avocados contain a mix of beta-sitosterol, campesterol, and stigmasterol

Physical activity and exercise play a significant role in maintaining healthy cholesterol levels. Regular exercise boosts the levels of HDL cholesterol, helps a person maintain a healthy weight, and enhances overall cardiovascular health. Obesity, in particular accumulation of fat around the waistline, is a risk factor for heart disease.

The Role of Nutritional Supplements

Commonly used nutritional supplements for cholesterol reduction include omega-3 fatty acids, niacin, and green tea extract. 

  • Omega-3 fatty acids, found in fish oil supplements, reduce triglycerides and lower LDL cholesterol levels
  • Niacin (vitamin B3) reduces cholesterol by lowering the production of very low-density lipoprotein (VLDL), a precursor to LDL cholesterol, and it elevates HDL cholesterol. Niacin also inhibits lipolysis, reducing the release of fatty acids and lowering the liver's production of triglycerides.
  • Green tea extract is rich in catechins and has been shown to lower LDL cholesterol.

The safe and effective use of supplements consists of monitoring for adverse events and efficacy. Appropriate dosage and regular monitoring are essential to assess both effectiveness and potential side effects. Examples of potential side effects of these supplements include:

  • Omega-3 fatty acids: In high doses, may cause gastrointestinal discomfort, including diarrhea and/or indigestion. Additionally, omega-3 supplements can impact blood clotting, posing a risk for people on anticoagulants
  • Niacin: Niacin can lead to flushing, itching, and warmth, particularly with immediate-release formulations and higher doses. In rare cases, niacin may pose more serious side effects such as liver damage
  • Green Tea Extract: Green tea extract may cause gastrointestinal discomfort and, in very rare cases, liver damage. The caffeine in green tea may cause insomnia, anxiety, or elevated heart rate in sensitive individuals 

Individuals should consult with a healthcare provider before starting any supplement regimen, especially those with existing health conditions or taking medications. Dosages should adhere to recommended levels, and regular monitoring is essential to assess both effectiveness and potential side effects. 

Lifestyle Modifications for Cholesterol Control

Lifestyle modifications such as smoking cessation, limiting alcohol intake, and reducing stress play a role in positively influencing cholesterol levels. Smoking lowers HDL (the “good”) cholesterol, damages blood vessels, and exacerbates the risk of atherosclerosis. Reducing or eliminating excessive alcohol intake has been linked to elevated triglyceride levels. Stress management techniques, such as meditation and exercise, reduce the release of stress hormones that may contribute to elevated LDL cholesterol. 

The benefits of these lifestyle adjustments have an impact on a person’s long-term cardiovascular health. Quitting smoking leads to a significant increase in HDL cholesterol levels over time, contributing to improved cardiovascular, respiratory, and vascular long-term outcomes. Furthermore, reducing alcohol intake has been linked to decreased triglyceride levels and a lower risk of coronary heart disease over time. Stress management practices promote overall well-being, and reduce the risk of some chronic diseases, in addition to having a positive impact on heart health. Implementing these lifestyle changes not only addresses immediate cholesterol concerns but also establishes a foundation for sustained cardiovascular health in the long run.

Integrating Natural and Pharmacologic Approaches

Integrating treatments for cholesterol to include both natural and pharmacologic methods is a potentially more effective strategy for cholesterol management. Natural modifications, consisting of dietary changes, regular exercise, supplement use, and stress management, contribute holistically to well-being. Concurrently, pharmacologic interventions add targeted approaches to optimize cholesterol balance. 

Consider these examples of the synergistic effects of combining natural and pharmacologic strategies for tailored and effective cholesterol management:

  • A 55-year-old male with well-controlled diabetes and chronically elevated cholesterol levels begins to consume a heart-healthy diet and starts a routine exercise regimen. Cholesterol testing six months later showed that his LDL levels remained high. A statin is added to his regimen. Six months after maintaining this combined regime, the patient’s serum lipid tests show a significant reduction in LDL cholesterol levels. 
  • A 60-year-old statin-intolerant female, with persistent elevated cholesterol levels, continues to have elevated cholesterol levels despite lifestyle modifications. She adds niacin supplementation and plant sterols to her diet. Her subsequent one-year follow-up lipid profile is now balanced. 

Monitoring and Adjusting Cholesterol Levels

Regular monitoring of cholesterol through blood tests and check-ups is crucial for maintaining cardiovascular health. The management of cholesterol is not a one-size-fits-all approach. Additionally, research has shown the dynamic nature and fluctuation of cholesterol levels over time, emphasizing the need for ongoing assessment and adjustment of interventions. For instance, lifestyle modifications may be initially recommended, but periodic monitoring may show that pharmacologic intervention is required to achieve an optimal cholesterol profile. 

Monitoring cholesterol levels enables healthcare providers to gauge the effectiveness of the various treatments and modify them if needed.

Adjusting interventions over time based on monitoring cholesterol levels involves careful consideration of individual responses and changing health conditions. Monitoring allows consideration and adjustment in several ways, including:

  • Lifestyle: If lifestyle changes alone are insufficient in achieving target cholesterol levels, further interventions may be necessary.
  • Medication Titration: Routine monitoring helps determine the efficacy of the prescribed drug and dosage. It is important to find the right balance since individual responses to medications can vary.
  • Treatment Goals: Monitoring cholesterol levels enables healthcare providers to determine if treatment goals are being met. If target levels are not achieved, adjustments to the treatment such as combining different classes of medications may be needed.
  • Risk Factor Assessment: Changes in risk factors for heart disease, such as blood pressure or diabetes status, may prompt adjustments to the treatment plan. 
  • Patient Education: Regular follow-ups provide opportunities for patient education. Understanding the importance of adherence to treatment plans empowers a person to proactively participate in their cardiovascular health management.

The Future of Cholesterol Management

The future of cholesterol management is promising, with the development of new drugs, natural interventions, and personalized medicine. There is the development of medications that target specific cholesterol pathways, offering potentially greater benefits with fewer side effects. Additionally, there is growing interest in natural interventions, like plant-based compounds, which may provide alternative approaches to support heart health. Healthcare providers are now able to create personalized treatment plans based on a person’s genetic risk profile. 

Understanding genetic factors influencing cholesterol metabolism allows for tailored interventions based on a person's unique genetic makeup. Examples of genetic factors that impact cholesterol include: 

  • Familial Hypercholesterolemia: Mutations in genes like LDLR, PCSK9, and APOB lead to high levels of LDL cholesterol. 
  • APOE Gene Variants: The APOE4 gene produces a protein that impacts lipid metabolism and has been linked to higher LDL cholesterol levels
  • LIPC Gene: The LIPC gene encodes hepatic lipase, an enzyme that plays a role in lipid metabolism. Variations in this gene can disrupt the balance between "good" and "bad" cholesterol.
  • ABCG8 and ABCG5 Genes: Variations in these genes can affect how efficiently cholesterol is transported and absorbed in the intestine, influencing overall cholesterol levels.
  • PCSK9 Gene Mutations: Mutations in the PCSK9 gene can alter the regulation of LDL receptors, leading to higher LDL cholesterol levels.

Understanding these genetic factors helps healthcare providers identify individuals at a higher risk of cholesterol-related issues and provide tailored treatment plans to effectively manage cholesterol levels. 


How to Lower Blood Cholesterol: Key Takeaways

Effectively managing cholesterol involves a multi-faceted approach. Lifestyle changes, including diet and exercise, form the foundation, supported by natural and pharmacologic interventions. This strategy not only addresses cholesterol levels but also considers individual risks, preferences, and tolerances, promoting a balanced and personalized approach to heart health. Routine cholesterol monitoring and check-ups have several benefits including monitoring, education, and the opportunity to modify interventions if the treatment goals are not being achieved.

The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article


  1. Abifadel, M., & Boileau, C. (2022). Genetic and molecular architecture of familial hypercholesterolemia. Journal of Internal Medicine, 293(2), 144–165.
  2. American Heart Association. (2020a, November 6). What Is Cholesterol?
  3. American Heart Association (Ed.). (2020, November 20). How To Get Your Cholesterol Tested.
  4. An Update on Lipoprotein(a): The Latest on Testing, Treatment, and Guideline Recommendations. (n.d.). American College of Cardiology.
  5. Apolipoprotein E (ApoE) Genotype by BostonHeart Diagnostics. (n.d.). Rupa Health.
  6. Barkas, F., Eirini Bathrellou, Nomikos, T., Panagiotakos, D. B., Liberopoulos, E. N., & Kontogianni, M. D. (2023). Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention. Nutrients, 15(13), 2845–2845.
  7. Baroni, M. G., Berni, A., Romeo, S., Arca, M., Tesorio, T., Sorropago, G., Di Mario, U., & Galton, D. J. (2003). Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Medical Genetics, 4(1).
  8. Bertagna, B. (2023, December 28). Health Benefits of Green Tea and How to Include It in Your Diet. Rupa Health.
  9. Boden, W. E., Probstfield, J. L., Anderson, T., Chaitman, B., Desvignes-Nickens, P., Koprowicz, K., McBride, R., Teo, K., & Weintraub, W. (2011). Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy. New England Journal of Medicine, 365(24), 2255–2267.
  10. Brandts, J., & Ray, K. K. (2023). Novel and future lipid-modulating therapies for the prevention of cardiovascular disease. Nature Reviews. Cardiology, 20(9), 600–616.
  11. Bruce, D. F., & PhD. (n.d.). Omega-3 Fish Oil Supplements: Benefits, Side Effects, and Uses. WebMD.
  12. Cicero, A. F. G., Fogacci, F., & Banach, M. (2019). Red Yeast Rice for Hypercholesterolemia. Methodist DeBakey Cardiovascular Journal, 15(3), 192.
  13. Cicero, A., Fogacci, F., & Zambon, A. (2021). Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar. Journal of the American College of Cardiology, 77(5), 620–628.
  14. Cleveland Clinic. (2019). Triglycerides & Heart Health | Cleveland Clinic. Cleveland Clinic.
  15. Cleveland Clinic. “Plant Sterols: How They Help Manage Cholesterol.” Cleveland Clinic, 30 July 2022,
  16. Contributors, W. E. (n.d.). Homocysteine and Heart Disease. WebMD.
  17. Cloyd, J. (2022, October 4). 4 Nutrition Hacks That Lower High Cholesterol. Rupa Health.
  18. Cloyd, J. (2023a, May 17). The Role Of Nutrition And Dietary Supplements In Preventing And Managing Cardiovascular Disease. Rupa Health.
  19. Cloyd, J. (2023b, December 4). Omega-3 Fatty Acids in Cardiovascular Health: A Functional Medicine Guide. Rupa Health.
  20. Cloyd, K. (2023, December 19). How to Interpret Your Lipid Panel Results. Rupa Health.
  21. Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., Evans, S., Law, M., MacMahon, S., Martin, S., Neal, B., Poulter, N., Preiss, D., Ridker, P., Roberts, I., & Rodgers, A. (2016). Interpretation of the evidence for the efficacy and safety of statin therapy. The Lancet, 388(10059), 2532–2561.
  22. Diorio, B. (2023, January 17). Why Most Functional Medicine Practitioners Say No To Alcohol. Rupa Health.
  23. Ganji, S. H., Kamanna, V. S., & Kashyap, M. L. (2003). Niacin and cholesterol: role in cardiovascular disease (review). The Journal of Nutritional Biochemistry, 14(6), 298–305.
  24. Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004). Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Journal of the American College of Cardiology, 44(3), 720–732.
  25. Harvard Health Publishing. (2015, March 17). An avocado a day may keep cholesterol at bay. Harvard Health.
  26. Kate, K. (2022, May 20). 3 Natural Ways to Lower Cholesterol Levels. Rupa Health.
  27. Kent, S. T., Rosenson, R. S., Avery, C. L., Chen, Y.-D. I., Correa, A., Cummings, S. R., Cupples, L. A., Cushman, M., Evans, D. S., Gudnason, V., Harris, T. B., Howard, G., Irvin, M. R., Judd, S. E., Jukema, J. W., Lange, L., Levitan, E. B., Li, X., Liu, Y., & Post, W. S. (2017). PCSK9
  28. Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke. Circulation: Cardiovascular Genetics, 10(4).
  29. Khan, S. U., Yedlapati, S. H., Lone, A. N., Hao, Q., Guyatt, G., Delvaux, N., Bekkering, G. E. (Trudy), Vandvik, P. O., Riaz, I. B., Li, S., Aertgeerts, B., & Rodondi, N. (2022). PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis. BMJ, 4(377), e069116.
  30. Lu, Y., Cheng, Z., Zhao, Y., Chang, X., Chan, C., Bai, Y., & Cheng, N. (2016). Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis. Atherosclerosis, 254, 215–227.
  31. Mauricio Teruo Tada, Rocha, V. Z., Isabella Ramos Lima, de, M., Paula, A., Miname, M. H., Nunes, V. S., Edna Regina Nakandakare, Helane, M., Jannes, C. E., Santos, R. D., José Eduardo Krieger, & Pereira, A. C. (2022). Screening of ABCG5 and ABCG8 Genes for Sitosterolemia in a Familial Hypercholesterolemia Cascade Screening Program. Circulation, 15(3).
  32. Mayo Clinic. (2020, September 29). Can triglycerides affect my heart health? Mayo Clinic.
  33. Mayo Clinic. (2022, September 2). Can lifestyle changes benefit your cholesterol? Mayo Clinic.
  34. Mayo Clinic. “Can Lifestyle Changes Benefit Your Cholesterol?” Mayo Clinic, 2 Sept. 2022,
  35. Mayo Clinic. (2022b, December 22). C-reactive protein test - Mayo Clinic. 
  36. Mayo Clinic Staff. (2017). Niacin. Mayo Clinic.
  37. Moyer, Melinda Wenner. “Beyond Statins: Other Medicines for High Cholesterol.” WebMD, 5 Jan. 2018,
  38. Murphy, S. A., Pedersen, T. R., Gaciong, Z. A., Ceska, R., Ezhov, M. V., Connolly, D. L., Jukema, J. W., Toth, K., Tikkanen, M. J., Im, K., Wiviott, S. D., Kurtz, C. E., Honarpour, N., Giugliano, R. P., Keech, A. C., Sever, P. S., & Sabatine, M. S. (2019). Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease. JAMA Cardiology, 4(7), 613.
  39. Neibling, K. (2023, April 26). Complementary and Integrative Medicine Treatments for Hypertension and Cardiovascular Disease. Rupa Health.
  40. Science Direct. “Brassicasterol - an overview | ScienceDirect Topics.”  Accessed 29 Jan. 2024.
  41. Science Direct. “Campesterol - an Overview | ScienceDirect Topics.”, Accessed 29 Jan. 2024.
  42. Sharifi, M., Futema, M., Nair, D., & Humphries, S. E. (2019). Polygenic Hypercholesterolemia and Cardiovascular Disease Risk. Current Cardiology Reports, 21(6).
  43. Sikand, G., & Severson, T. (2020). Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction. American Journal of Preventive Cardiology, 4(19), 100106.
  44. Silverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016). Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions. JAMA, 316(12), 1289.
  45. Stanley, M., & Adigun, R. (2020). Rhabdomyolysis. PubMed; StatPearls Publishing.
  46. Sweetnich, J. (2023, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health.
  47. Tang, J L, et al. “Systematic Review of Dietary Intervention Trials to Lower Blood Total Cholesterol in Free-Living Subjects   Commentary: Dietary Change, Cholesterol Reduction, and the Public Health---What Does Meta-Analysis Add?” BMJ, vol. 316, no. 7139, 18 Apr. 1998, pp. 1213–1220,
  48. Tscharre, M., Herman, R., Rohla, M., Piackova, E., Vargas, K. G., Farhan, S., Freynhofer, M. K., Weiss, T. W., & Huber, K. (2019). Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention. Journal of Clinical Lipidology, 13(1), 115–122.
  49. Watts, G. F., Gidding, S. S., Hegele, R. A., Raal, F. J., Sturm, A. C., Jones, L. K., Sarkies, M. N., Khalid Al-Rasadi, Blom, D. J., Daccord, M., Sarah de Ferranti, Folco, E., Libby, P., Mata, P., Hapizah Nawawi, Ramaswami, U., Ray, K. K., Stefanutti, C., Yamashita, S., & Pang, J. (2023). International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nat Rev Cardiol, 20(12), 845–869.
  50. WebMD. “Green Tea: Uses, Side Effects, Interactions, Dosage, and Warning.”, 2019,
  51. Wen, Y. T., Dai, J. H., & Gao, Q. (2014). Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: A meta-analysis of randomized controlled trials. Nutrition, Metabolism and Cardiovascular Diseases, 24(5), 470–475.
  52. Yoshimura, H. (2023, July 17). Using Functional Medicine As Personalized Medicine. Rupa Health.
  53. Yurth, E. (2021, July 20). How to Identify Risk for Cardiovascular Disease Using ApoB/ApoA1 Blood Testing. Rupa Health.
  54. Zamani, M., Mahnaz Rezaei Kelishadi, Damoon Ashtary-Larky, Niusha Amirani, Goudarzi, K., Iman Attackpour Torki, Bagheri, R., Matin Ghanavati, & Omid Asbaghi. (2023). The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis. Front Nutr, 9(10).
Subscribe to the Magazine for free. to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.